We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

PEGS Europe 2018 – Protein & Antibody Engineering Summit

Visit us at Booth #619 to learn more about MOA-based bioassays for measurement of antibody function, potency and stability.

  • Lisbon Congress Center, Lisbon, Portugal.
  •  Monday, November 12, 2018 – Friday, November 16, 2018

Ask us about:

  • Target Cell Killing Assays
  • Functional Bioassays
  • Bioanalytical Tools for Mass Spec
FREE bioassay!

PODIUM PRESENTATION

Development and Application of MOA-Based Reporter Bioassays for Immunotherapy Drug Development
Presented by Mei Cong, Director, Custom Assay Services
Wednesday, November 14, 10:05am

POSTER PRESENTATIONS

Quantitative Cell-Based Bioassays to Advance Immunotherapy Programs Targeting Immune Checkpoint Receptors
Presented by Reka Nagy, Strategic Collaborations Manager
Reproducible MOA-Reflecting Reporter-Based Bioassays to Enable Drug Development of Biosimilars and Biobetters
Presented by Mei Cong, Director, Custom Assay Services
Measurement of Fc-Mediated ADCC and CDC Activity of Anti-TNFα and Anti-VEGF Therapeutic Antibodies using Reporter-Based Bioassays and Engineered TNFα+ and VEGF+ Target Cells
Presented by Vanessa Ott, Manager, Biologics
Measurement of Target Cell-Specific Killing Using a Novel Highly Sensitive Bioluminescent Assay
Presented by Gijs Jochems, General Manager
Evaluating a No-Wash Rapid FcRn Immunoassay to Guide the Development of Antibody Therapeutics
Presented by Nidhi Nath, Sr Research Scientist
Bioluminescent Assays for T-Cell Responsiveness: From Changes in Metabolism to Target Specific Cell Killing
Presented by Jolanta Vidugiriene, Sr Research Scientist
An Automated Method to Suppress Artificial Non-Enzymatic PTMs During Sample Preparation for Peptide Mapping
Presented by Vanessa Ott, Manager, Biologics

Share With a Friend

We will NOT sell your personal information, such as your name or email address, to third parties or use your email address to send you marketing materials. The email and names entered will only be used to identify the sender and recipient of the email.

Send Cancel